COVID-19 Coding & Billing

The COVID-19 pandemic continues to create new requirements for hospital coding and billing. Here's a collection of resources to keep you informed.

News & Articles

Latest Updates Related to COVID-19 Coding and Billing: June 8, 2021

The COVID-19 public health emergency continues to inspire changes to coding and billing practices and guidelines that impact physicians, healthcare providers, and coding and billing professionals. Several organizations recently announced changes related to COVID-19 that could impact all healthcare professionals.

Learn More

COVID-19 Coding & Billing Updates

With the arrival of vaccines, the world turned a corner on the fight against COVID-19, and behind the frontlines, mid-revenue cycle personnel have been doing their best to provide support. In this article, we cover the coding and billing changes that have happened since October 2020.

Learn More

Ask a Rev Cycle Expert: Is there a new HCPCS code for Hemospray®?

Is there a new HCPCS code for Hemospray®?

Learn More

Ask a Rev Cycle Expert: Token or No Charge for COVID-19 Drug Codes?

For the new COVID-19 "drug" codes provided below, should we bill a "token" charge on the claim? Drugs are provided free (at this point), and guidance is "No" charge if provided for free, but would like to confirm proper coding and claim submission as I have seen it referenced both ways, to add a token charge, and to not bill at all!

Learn More

New ICD-10-CM and ICD-10-PCS Codes Announced For January 1, 2021

New International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) and Procedure Coding System (ICD-10-PCS) codes have been released with an effective date of January 1, 2021. The new codes are related to reporting COVID-19 conditions and services.

Learn More

FDA Issues Emergency Use Authorizations (EUAs) for COVID-19 Treatments

The U.S. Food & Drug Administration (FDA) has issued additional Emergency Use Authorizations (EUAs) for drugs to treat the COVID-19 disease. Baricitinib (Olumiant) is approved for inpatient use only, while the combination of the drugs casirivimab and imdevimab has been approved for outpatient use.

Learn More

Past Events & Webinars

April 9, 2020

Navigating the COVID-19 Billing Guidelines to Ensure Regulatory Compliance

Join us for a 60-minute complimentary webinar where we will break down the existing COVID-19 billing and reimbursement guidelines for physicians and other healthcare providers.

Learn More

April 23, 2020

Updated COVID-19 Billing Guidelines for Hospitals and Physicians

Join us for a one-hour complimentary webinar where we will break down the existing COVID-19 billing and reimbursement guidelines for physicians and other healthcare providers, including info on telehealth.

Learn More

May 5, 2020

Sweeping COVID-19 Changes and Regulatory Waivers Announced

The Trump administration just issued a second round of sweeping changes and regulatory waivers to support the U.S. healthcare system during the COVID-19 pandemic. We will gather all the details and review them with you on this complimentary 45-minute webinar.

Learn More

May 6, 2020

Live COVID-19 Coding Q&A

In this complimentary 45-minute webinar, we’ll provide a brief update and clarification on the COVID-19 coding and billing guidelines. After the brief update, we’ll spend the rest of the time fielding your questions related to the COVID-19 Public Health Emergency.

Learn More

May 13, 2020

Billing For Telehealth Services During COVID-19 Public Health Emergency

We get a lot of questions around billing and coding for telehealth services right now. In this complimentary 45-minute webinar, we’ll focus on details surrounding billing for telehealth during the COVID-19 public health emergency. 1 AAPC CEU will be awarded to those that attend live.

Learn More

May 20, 2020

Leading a Remote Team through COVID-19: A Panel Discussion with Revenue Cycle Leaders

Join us for a special 30-minute complimentary roundtable discussion with revenue cycle leaders who have spent the last few months in the trenches along with you, dealing with these issues and more. Learn what worked—what didn’t—and gather some new ideas that could benefit your own teams during this unprecedented time.

Learn More